Minnesota's New Prescription Drug Price Transparency Reporting: What You Need to Know | by: Sumeet Singh, Founder & Chairman | Article Posted: November 6, 2023 | In recent years, the transparency surrounding prescription drug pricing has become a focal point for...
The Coronavirus and the Pharmaceutical Supply Chain As the coronavirus wreaks havoc around the globe, the pharmaceutical supply chain needs to...
How Telemedicine Has Made Generic Drugs Sexy Since 2017, Direct-to-Consumer (DTC) startups (some engaged by Pharma Solutions!) have cropped up to...
Most of the content you see from Pharma Solutions in regards to the DQSA focuses on Title II: Drug Supply Chain Security Act, which outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. Title II primarily affects manufacturers, 3PLs, drug distributors and pharmacies.
Bernie Sanders and other top Democrats have made drug pricing a hot topic in US politics, especially with the election coming up next year. As such, there have been a flurry of bills and solutions to the perceived problem – and Drug Importation may become a reality sooner rather than later.
Anti-Trust Activities in the Dental Supply Market Product access and pricing are always at the center-point of supply chains–and the healthcare...
The Unforeseen Consequence of Colorado’s Insulin Price Cap Photo courtesy of the Los Angeles Times Drug pricing has been a huge, very public issue...
